Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study

Lindskog Magnus and Laurell Anna and Kjellman Anders and Melichar Bohuslav and Rey Pablo Maroto and Zielinski Henryk and Villacampa Felipe and Bigot Pierre and Bajory Zoltán and Parikh Omi and Alba David Vazquez and Jellvert Ðsa and Flaskó Tibor and Gallardo Enrique and Ribal Caparros Maria Jose and et al.: Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study.
EUROPEAN UROLOGY OPEN SCIENCE, 40. pp. 38-45. ISSN 2666-1691 (2022)

[thumbnail of 33033299.pdf]
Preview
Text
33033299.pdf - Published Version

Download (861kB) | Preview
Item Type: Journal Article
Journal or Publication Title: EUROPEAN UROLOGY OPEN SCIENCE
Date: 2022
Volume: 40
Page Range: pp. 38-45
ISSN: 2666-1691
Faculty/Unit: Albert Szent-Györgyi Medical School
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 33033299
DOI azonosító: https://doi.org/10.1016/j.euros.2022.03.012
Date Deposited: 2023. Feb. 20. 12:16
Last Modified: 2023. Feb. 20. 12:16
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/26540
Web of Science® Times Cited: 5 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year